SEPN
Septerna Inc.

572
Mkt Cap
$1.04B
Volume
1.52M
52W High
$28.99
52W Low
$4.17
PE Ratio
-15.41
SEPN Fundamentals
Price
$23.27
Prev Close
$19.24
Open
$19.69
50D MA
$19.35
Beta
1.39
Avg. Volume
352,628.00
EPS (Annual)
-$1.62
P/B
2.67
Rev/Employee
$14,333.33
Loading...
Loading...
News
all
press releases
Septerna (NASDAQ:SEPN) SVP Daniel Long Sells 3,501 Shares
Septerna, Inc. (NASDAQ:SEPN - Get Free Report) SVP Daniel Long sold 3,501 shares of Septerna stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
HC Wainwright Reduces Earnings Estimates for Septerna
Septerna, Inc. (NASDAQ:SEPN - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Septerna in a research report issued on Tuesday, November 11th. HC...
MarketBeat·23h ago
News Placeholder
Daniel Long Sells 3,501 Shares of Septerna (NASDAQ:SEPN) Stock
Septerna, Inc. (NASDAQ:SEPN - Get Free Report) SVP Daniel Long sold 3,501 shares of the business's stock in a transaction on Monday, November 10th. The shares were sold at an average price of $18.06...
MarketBeat·2d ago
News Placeholder
HC Wainwright Forecasts Septerna's Q4 Earnings (NASDAQ:SEPN)
Septerna, Inc. (NASDAQ:SEPN - Free Report) - Investment analysts at HC Wainwright decreased their Q4 2025 earnings estimates for Septerna in a report issued on Tuesday, November 11th. HC Wainwright...
MarketBeat·2d ago
News Placeholder
Septerna (NASDAQ:SEPN) Trading 6.7% Higher Following Analyst Upgrade
Septerna (NASDAQ:SEPN) Trading 6.7% Higher on Analyst Upgrade...
MarketBeat·4d ago
News Placeholder
Septerna (NASDAQ:SEPN) Releases Earnings Results, Misses Estimates By $0.28 EPS
Septerna (NASDAQ:SEPN - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of...
MarketBeat·5d ago
News Placeholder
Septerna, Inc. (SEPN) Reports Q3 Loss, Misses Revenue Estimates
Septerna, Inc. (SEPN) delivered earnings and revenue surprises of -147.37% and -71.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of +13.79% and -4.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·16d ago
News Placeholder
Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last?
Arcturus Therapeutics (ARCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·25d ago

Latest SEPN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.